IRS1 and Alzheimer disease: This injection effectively increases brain IDE in 3xTg-AD mice, and down-regulates brain protein levels of serine-phosphorylated insulin receptor substrate-1 (IRS-1), pS616 and pS636/639 in 13-month-old 3xTg-AD mice, respectively [70,71].